Outcome of Treatment of MDR-TB Patients with Standardized Regimens; Iran's Experience 2002-2006

被引：1
|
作者：
Masjedi, M. R. [1 ]
Tabarsi, P. [1 ]
Chitsaz, E. [1 ]
Velayati, A. [1 ]
机构：
[1] NRITLD, Tehran, Iran
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2008年 / 12卷
关键词：
D O I：
10.1016/j.ijid.2008.05.679
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E250 / E251
页数：2
相关论文
共 50 条
  • [41] Refining MDR-TB treatment regimens for ultra short therapy (TB-TRUST): study protocol for a randomized controlled trial
    Weng, Taoping
    Sun, Feng
    Li, Yang
    Chen, Jiazhen
    Chen, Xinchang
    Li, Rong
    Ge, Shijia
    Zhao, Yanlin
    Zhang, Wenhong
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [42] Linezolid-induced peripheral neuropathy in patients receiving MDR-TB treatment
    Skyllberg, Erik
    Young, Rebekah
    Sharma, Akhilesh
    Chen, Christabelle
    Tiberi, Simon
    White, Veronica
    Kunst, Heinke
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [43] Refining MDR-TB treatment regimens for ultra short therapy (TB-TRUST): study protocol for a randomized controlled trial
    Taoping Weng
    Feng Sun
    Yang Li
    Jiazhen Chen
    Xinchang Chen
    Rong Li
    Shijia Ge
    Yanlin Zhao
    Wenhong Zhang
    BMC Infectious Diseases, 21
  • [44] Shortening MDR-TB treatment: is treating more patients with fewer drugs better?
    Akkerman, O. W.
    Tiberi, S.
    Alffenaar, J-W.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2021, 25 (06) : 419 - 420
  • [45] Treatment Results of Multidrug Resistant Tuberculosis (MDR-TB) Patients in the Aegean Region
    Karaman, Onur
    Varol, Yelda
    Bicmen, Can
    Akarca, Tulay
    Dereli, Sevket
    Ozbakir, Didem
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [46] Occurrence and predictors of adverse events associated with Linezolid in the treatment of patients with MDR-TB
    Oehadian, A.
    Bastos, M. L.
    Centis, R.
    D'Ambrosio, L.
    Migliorie, G. B.
    Santoso, P.
    Ruslami, R.
    Menzies, D.
    PULMONOLOGY, 2024, 30 (02): : 184 - 187
  • [47] Treatment outcomes of patients with MDR-TB and its determinants at referral hospitals in Ethiopia
    Wakjira, Mengistu K.
    Sandy, Peter T.
    Mavhandu-Mudzusi, A. H.
    PLOS ONE, 2022, 17 (02):
  • [48] Improved treatment outcome of MDR-TB in Eastern Taiwan: Reducing default rate by DOTS Plus
    Lin, Chih Bin
    Lee, Jen-Jyh
    Sun, Hung-Chieh
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [49] Treatment outcome of multi-drug resistant tuberculosis (MDR-TB) patients at a tertiary care center of Northern India
    Takhar, Rajendra Prasad
    Saxena, Anil
    Khangarot, Suman
    Garg, Rashmi
    Bansiwal, Babulal
    Shringi, Kamal Nayan
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [50] Attrition and delays before treatment initiation among patients with MDR-TB in China (2006-13): Magnitude and risk factors
    Xu, Caihong
    Li, Renzhong
    Shewade, Hemant Deepak
    Jeyashree, Kathiresan
    Ruan, Yunzhou
    Zhang, Canyou
    Wang, Lixia
    Zhang, Hui
    PLOS ONE, 2019, 14 (04):
12345